iMPACT - Improving Patient Access to Cancer Clinical Trials
Improving Patient Access to Cancer Clinical Trials
IMPACT is a 3-year pilot study with a comprehensive approach to improving patient enrollment, retention, minority participation and equitable access in oncology trials. UCSF is excited to be one of several institutions participating in this landmark study.
The iMPACT Study is a pilot study for IMproving Patient Access to cancer Clinical Trials using a sliding scale financial reimbursement program for ancillary expenses associated with clinical trial participation (gas, parking, flights, hotels, Ubers/Lyfts/taxis, rental car, travel companion, etc). All adult cancer patients being considered for a therapeutic clinical trial are eligible. The study is sponsored by the Lazarex Cancer Foundation, a nonprofit charity dedicated to improving patient enrollment, retention, minority participation, and equitable access in oncology trials. This study is now accruing patients, as of April 2019.
- October 30, 2019 Why minority representation in medical research is a matter of life and death
- April 15, 2019 UCSF Study Aims to Increase Diversity in Cancer Clinical Trials
- November 5, 2018 Legislative Efforts to Pay Trial Participants Pay Off
- November 2, 2018 New PA law hopes to break down 'financial barrier' for cancer patients seeking clinical trial care
- October 31, 2018 Working to help cancer patients afford treatment in Pennsylvania
- October 18, 2018 2 Major Victories For Cancer Patients Nationwide As Bills Promoting Equal Access To Cancer Trials Become Law
Impact Summary Report
We improve the outcome of cancer care for advanced stage cancer patients and the medically underserved, by providing assistance with costs for FDA clinical trial participation, identification of clinical trial options, community outreach and education. For over a decade, Lazarex Cancer Foundation has uniquely provided these services as a public charity. Read more